Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Fibrinogen beta-Kette

Das FGB-Gen kodiert die beta-Komponente des Fibrinogens, einem wichtigen Gerinnungsfaktor. Mutationen führen zu verschiedenen autosomal dominanten oder rezessiven Gerinnungsstörungen mit Blutungs- oder Thromboseneigung.

Gentests:

Klinisch Untersuchungsmethoden Familienuntersuchung
Bearbeitungszeit 5 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Direkte Sequenzierung ausgewählter Gen-Abschnitte
Bearbeitungszeit 5 Tage
Probentyp genomische DNS

Verknüpfte Erkrankungen:

Afibrinogenämie
FGA
FGB
FGG
Dysfibrinogenemie
FGA
FGB
FGG

Referenzen:

1.

Koopman J et al. (1992) Abnormal fibrinogens IJmuiden (B beta Arg14--Cys) and Nijmegen (B beta Arg44--Cys) form disulfide-linked fibrinogen-albumin complexes.

external link
2.

Wassel CL et al. (2011) Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe).

external link
3.

Vu D et al. (2005) Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia.

external link
4.

Petzelbauer P et al. (2005) The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury.

external link
5.

Asselta R et al. (2004) Missense or splicing mutation? The case of a fibrinogen Bbeta-chain mutation causing severe hypofibrinogenemia.

external link
6.

Spena S et al. (2002) Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites.

external link
7.

Asselta R et al. (2002) Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia.

external link
8.

Lounes KC et al. (2001) The impaired polymerization of fibrinogen Longmont (Bbeta166Arg-->Cys) is not improved by removal of disulfide-linked dimers from a mixture of dimers and cysteine-linked monomers.

external link
9.

O'Donnell CJ et al. (2001) Genetic and environmental contributions to platelet aggregation: the Framingham heart study.

external link
10.

Duga S et al. (2000) Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion.

external link
11.

Tybjaerg-Hansen A et al. (1997) A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study.

external link
12.

Chung DW et al. (1983) Characterization of complementary deoxyribonucleic acid and genomic deoxyribonucleic acid for the beta chain of human fibrinogen.

external link
13.

Ebert RF et al. (1983) Fibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis.

external link
14.

Meyer M et al. (1988) A new genetic fibrinogen variant (fibrinogen Erfurt I). Structurally characterized by an abnormal B beta-chain and present both in plasma and platelets.

external link
15.

Schmelzer CH et al. (1988) A polymorphism at B beta 448 of fibrinogen identified during structural studies of fibrinogen Baltimore II.

external link
16.

Liu CY et al. (1985) Characterization of fibrinogen New York 1. A dysfunctional fibrinogen with a deletion of B beta(9-72) corresponding exactly to exon 2 of the gene.

external link
17.

Humphries SE et al. (1987) Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations.

external link
18.

Berg K et al. (1989) DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration.

external link
19.

Yoshida N et al. (1991) A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.

external link
20.

Koopman J et al. (1992) Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr.

external link
21.

Fowkes FG et al. (1992) Fibrinogen genotype and risk of peripheral atherosclerosis.

external link
22.

Orphanet article

Orphanet ID 121788 external link
23.

NCBI article

NCBI 2244 external link
24.

OMIM.ORG article

Omim 134830 external link
Update: 14. August 2020
Copyright © 2005-2024 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz | Impressum